Global Self-monitoring Blood Glucose Devices Market 2015-2019
About self-monitoring blood glucose device
Self-monitoring blood glucose device is a home-based electronic device. It consists of a glucose sensor and a transmitter that transmits information about glucose levels through radiowaves from the sensor to a receiver, where it is displayed. The regular usage of self-monitoring blood glucose devices can improve self-management of diabetes and prompt an individual to undergo proper diabetes treatment.
Technavio's analysts forecast the global self-monitoring blood glucose devices market to grow at a CAGR of 10.47% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the global self-monitoring blood glucose devices market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of self-monitoring blood glucose devices.Technavio's report, Global Self-monitoring Blood Glucose Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Automotive Clutch Market: Abbott Laboratories, Arkray, Bayer Healthcare, LifeScan and Roche Diagnostics
Other Prominent Vendors in the market are: Animas, B. Braun Melsungen, Bionime, Bioptik Technology, Chongqing Haray International Business, Dexcom, Gluco-Ease, LabStyle Innovations, Integrity Applications, M Pharmaceutical, Medtronic, Medisana, Nipro Diagnostics, Nova Biomedical, OrSense, Sunrising Enterprise, Tekcapital, Grove Instruments and Wuhan HNC Technology
Commenting on the report, an analyst from Technavio’s team said: “Though diabetes is a chronic metabolic condition, it can be controlled with proper medication, and dietary and lifestyle management. Most people prefer SMBG devices for convenient monitoring of blood glucose levels. Moreover, regular blood glucose testing is the cornerstone of effective diabetes management. Usage of blood glucose test strips and meters at home can help patients obtain an accurate blood glucose level reading within few seconds. This trend is anticipated to have a significant impact on the SMBG devices market.”
According to the report, according to WHO, the number of people aged 60 and above will increase tremendously by 2050. By 2030, more than 22% of the world's population will be over 65 years. Almost one-third of the elderly people over the age of 65 are affected by diabetes. The Americas is reported to have a high elderly population, which is estimated to grow at a minimal rate by 2050. Similarly, in Europe, the elderly population will increase by 2050 because of an increase in life expectancy and advances in the healthcare industry. The percentage of the elderly population in APAC is low, including China and India. However, the region will have the largest aging population by 2050.
Further, the report states that the presence of alternative methods of glucose monitoring could hinder the growth of the SMBG devices market.
Abbott Laboratories, Arkray, Bayer Healthcare, LifeScan, Roche Diagnostics, Animas, B. Braun Melsungen, Bionime, Bioptik Technology, Chongqing Haray International Business, Dexcom, Gluco-Ease, LabStyle Innovations, Integrity Applications, M Pharmaceutical, Medtronic, Medisana, Nipro Diagnostics, Nova Biomedical, OrSense, Sunrising Enterprise, Tekcapital, Grove Instruments, Wuhan HNC Technology